Back to Results

Copeptin and Nonalcoholic Fatty Liver Disease

Study category: Diabetes & Hormone Disorders

Is this Study for You?

Let's Get Started!

Description

See above

Details
Age

Adult

Eligibility

Obese 30-40 BMI, age 30-75

Detailed Eligibility: Diabetes, other liver disease or eGFR<45.

Phase

Pilot - A pilot Study is used to obtain information, and work out the logistics and management, deemed necessary for further Research Studies.

Type of Study

Observational

Locations

Anschutz Health and Wellness
UCD Anschutz Health & Wellness Center
University of Colorado Hospital

Principal Investigator
Thomas Jensen

Thomas Jensen

Study ID

Protocol Number: 17-1160

ClinicalTrials.gov: NCT03254563

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers